buserelin has been researched along with Cardiovascular Diseases in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aro, J; Hansson, E; Juusela, H; Permi, J; Ruutu, M | 1 |
| Moffat, LE | 1 |
2 trial(s) available for buserelin and Cardiovascular Diseases
| Article | Year |
|---|---|
Polyestradiol phosphate (160 mg/month) or LHRH analog (buserelin depot) in the treatment of locally advanced or metastasized prostatic cancer. The Finnprostate Group.
Topics: Adenocarcinoma; Aged; Buserelin; Cardiovascular Diseases; Estradiol; Estradiol Congeners; Finland; Humans; Male; Prospective Studies; Prostatic Neoplasms | 1993 |
Comparison of Zoladex, diethylstilbestrol and cyproterone acetate treatment in advanced prostate cancer.
Topics: Androgen Antagonists; Breast; Buserelin; Cardiovascular Diseases; Cyproterone; Cyproterone Acetate; Diethylstilbestrol; Goserelin; Humans; Male; Prospective Studies; Prostatic Neoplasms | 1990 |